<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-marinedrugs-17-00139" class="ref">
 <label class="label">32.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Vázquez</surname>
    <given-names class="given-names">J.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Blanco</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Massa</surname>
    <given-names class="given-names">A.E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Amado</surname>
    <given-names class="given-names">I.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pérez-Martín</surname>
    <given-names class="given-names">R.I.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Production of fish protein hydrolysates from 
   <italic class="italic">Scyliorhinus canicula</italic> discards with antihypertensive and antioxidant activities by enzymatic hydrolysis and mathematical optimization using response surface methodology
  </article-title>
  <source class="source">Mar. Drugs</source>
  <year class="year">2017</year>
  <volume class="volume">15</volume>
  <elocation-id class="elocation-id">306</elocation-id>
  <pub-id pub-id-type="doi" class="pub-id">10.3390/md15100306</pub-id>
  <?supplied-pmid 28994711?>
  <pub-id pub-id-type="pmid" class="pub-id">28994711</pub-id>
 </element-citation>
</ref>
